Table 3.
Graft Rejection and Histological Assessment
ISP n = 32 |
NR n = 32 |
p | |
---|---|---|---|
M3 Fibrosis, Mean ± SD | 0.31 ± 0.09 | 0.32 ± 0.14 | 0.68d |
Missing, n | 14 | 16 | |
M12 Fibrosis, Mean ± SD | 0.37 ± 0.12 | 0.30 ± 0.10 | 0.08a |
Missing, n | 16 | 16 | |
Clinical acute rejection, n (%) | 6 (19) | 5 (18) | 0.93c |
Missing, n | 1 | 5 | |
Borderline changes | |||
M3, n (%) | 10 (45) | 4 (21) | 0.10c |
Missing, n | 10 | 13 | |
M12, n (%) | 13 (68) | 4 (22) | 0.008b |
Missing, n | 13 | 14 | |
cv score M3, n (%) | 0.83b | ||
0 | 5 (25) | 5 (33) | |
1 | 11 (55) | 6 (40) | |
2 | 2 (10) | 3 (20) | |
3 | 2 (10) | 1 (7) | |
Missing, n | 12 | 17 | |
cv score M12, n (%) | 0.39b | ||
0 | 5 (26) | 8 (44) | |
1 | 12 (63) | 6 (33) | |
2 | 1 (5) | 2 (11) | |
3 | 1 (5) | 2(11) | |
Missing, n | 13 | 14 |
ISP in situ perfusion, NR normothermic recirculation
aWilcoxon test
bFisher exact test
cChi square
dStudent test